Please scroll down to bottom of email to add or remove your name from the IAS mailing list.

IAS Logo

International Atherosclerosis
Society
Literature e-Newsletter
April 2009

Stethoscope, medicine, world, fruit, lab

SEARCH TOPICS
Aging
Apo / Lipoproteins
Biomarkers
Diabetes
Drug Therapy
Genetics of CVD
   
Hypertension
Imaging
Immunology
Inflammation
Innovative Techniques / Modeling
Metabolic Syndrome
   
Nutrition, Diet, and Metabolism
Obesity
Oxidative Stress / Antioxidants
Pediatrics
Plaque Biology
Renal Function / Renal Disease
   
Risk Factors
Stroke
Vascular Biology
Vascular Calcification
Recommended Articles

IAS AFFILIATIONS

International Chair on Cardiometabolic Risk

Metabolic Syndrome Institute


IAS WEBSITE EDITORIAL BOARD
Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta

Milan, Italy
Emanuela Folco
Milan, Italy
Ann Jackson
Houston, TX, USA

Website Editors
Gianpaolo Bagnato

Milan, Italy
Annamaria Scimone
Milan, Italy
Yelonda Williams
Dallas, TX
Mandi Wong

Dallas, TX

 

AGING

  • Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.
    (Collins AR, et al. Circ Res. 2009 Mar 27;104(6):e42-54. Epub 2009 Mar 5.)
    View Abstract

APO / LIPOPROTEINS

  • Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.
    (Chhatriwalla AK, et al. J Am Coll Cardiol. 2009 Mar 31;53(13):1110-5.)
    View Abstract
  • Tauhe role of lipoprotein-associated phospholipase A(2) in atherosclerosis may depend on its lipoprotein carrier in plasma.
    (Tellis CC, et al. Biochim Biophys Acta. 2009 Mar 9. [Epub ahead of print])
    View Abstract

BIOMARKERS

  • Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
    (Koenig W. Ann Med. 2009 Mar 16:1-12. [Epub ahead of print])
    View Abstract

DIABETES

  • Early atherosclerosis and vascular inflammation in mice with diet-induced type 2 diabetes.
    (Bartels ED, et al. Eur J Clin Invest. 2009 Mar;39(3):190-9.)
    View Abstract
  • Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: the Multi-Ethnic Study of Atherosclerosis.
    (Colangelo LA, et al. Diabetes Care. 2009 Mar 16. [Epub ahead of print])
    View Abstract

DRUG THERAPY

  • Role of ezetimibe in the management of patients with atherosclerosis.
    (Hamilton P. Coron Artery Dis. 2009 Mar;20(2):169-74.)
    View Abstract
  • Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis.
    (Kerekes G, et al. Clin Rheumatol. 2009 Mar 25. [Epub ahead of print])
    View Abstract
  • Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis.
    (Tan TY, et al. Epilepsia. 2009 Mar 9. [Epub ahead of print])
    View Abstract
  • Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR mice.
    (Vilskersts R, et al. Pharmacology. 2009 Mar 27;83(5):287-293. [Epub ahead of print])
    View Abstract
  • The role of a murine transplantation model of atherosclerosis regression in drug discovery.
    (Feig JE, et al. Curr Opin Investig Drugs. 2009 Mar;10(3):232-8.)
    View Abstract

GENETICS OF CARDIOVASCULAR DISEASE

  • C-338A polymorphism of the endothelin-converting enzyme-1 gene and the susceptibility to carotid atherosclerosis.
    (Jin Z, et al. Microvasc Res. 2009 Mar 14. [Epub ahead of print])
    View Abstract
  • Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion.
    (Steinbrugger I, et al. Mol Vis. 2009;15:609-18. Epub 2009 Mar 27.)
    View Abstract
  • Microarray analysis of gene expression in the mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility.
    (Yuan Z, et al. Am J Physiol Heart Circ Physiol. 2009 Mar 20. [Epub ahead of print])
    View Abstract
  • CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.
    (An G, et al. Mol Immunol. 2009 May;46(8-9):1702-1709. Epub 2009 Mar 17.)
    View Abstract
  • Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.
    (Crosslin DR, et al. Hum Genet. 2009 Mar;125(2):217-29. Epub 2009 Jan 8.)
    View Abstract
  • Molecular genetics of atherosclerosis.
    (Roy H, et al. Hum Genet. 2009 Mar 20. [Epub ahead of print])
    View Abstract
  • Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis.
    (Muendlein A, et al. Atherosclerosis. 2009 Mar 19. [Epub ahead of print])
    View Abstract
  • Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.
    (Tsai MY, et al. Clin Chem. 2009 Mar;55(3):481-8. Epub 2009 Jan 8.)
    View Abstract
  • Methylentetrahydrofolate reductase and nitric oxide synthase polymorphism in patients with atherosclerosis and diabetes.
    (Szabó GV, et al. Pathol Oncol Res. 2009 Mar 29. [Epub ahead of print])
    View Abstract
  • Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.
    (Talbert ME, et al. Hum Genet. 2009 Mar;125(2):153-62. Epub 2008 Dec 13.)
    View Abstract

HYPERTENSION

  • The predictive role of C-reactive protein in subjects with hypertension and subclinical atherosclerosis.
    (Rizzo M, et al. Intern Med J. 2009 Mar 23. [Epub ahead of print])
    View Abstract

IMAGING

  • Detection of intracranial atherosclerosis: which imaging techniques are available in European hospitals?
    (Balucani C, et al. Stroke. 2009 Mar;40(3):726-9. Epub 2009 Jan 8.)
    View Abstract
  • Nanoparticles for optical molecular imaging of atherosclerosis.
    (Douma K, et al. Small. 2009 Mar;5(5):544-57.)
    View Abstract
  • Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging.
    (Floris-Moore M, et al. AIDS. 2009 Mar 31. [Epub ahead of print])
    View Abstract
  • Atherosclerosis: contrast-enhanced MR imaging of vessel wall in rabbit model--comparison of gadofosveset and gadopentetate dimeglumine.
    (Lobbes MB, et al. Radiology. 2009 Mar;250(3):682-91.)
    View Abstract
  • Imaging coronary and extracoronary atherosclerosis: feasibility and impact of whole-body computed tomography angiography.
    (Napoli A, et al. Eur Radiol. 2009 Mar 11. [Epub ahead of print])
    View Abstract
  • Inflammation imaging in atherosclerosis.
    (Rudd JH, et al. Arterioscler Thromb Vasc Biol. 2009 Mar 20. [Epub ahead of print])
    View Abstract
  • Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis.
    (Tahara N, et al. J Nucl Med. 2009 Mar;50(3):331-4. Epub 2009 Feb 17.)
    View Abstract
  • In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis.
    (Worthley SG, et al. Int J Cardiovasc Imaging. 2009 Mar;25(3):251-7. Epub 2008 Nov 1.)
    View Abstract
  • Longitudinal ultrasound evaluation of carotid atherosclerosis in one, two and three dimensions.
    (Mallett C, et al. Ultrasound Med Biol. 2009 Mar;35(3):367-75. Epub 2008 Nov 8.)
    View Abstract
  • The role of CT angiography in risk stratification for atherosclerosis.
    (Schmermund A, et al. Curr Atheroscler Rep. 2009 Mar;11(2):111-7.)
    View Abstract
  • Amounts of aortic atherosclerosis in patients with aortic stenosis as determined by transesophageal echocardiography.
    (Osranek M, et al. Am J Cardiol. 2009 Mar 1;103(5):713-7. Epub 2009 Jan 15.)
    View Abstract
  • Can scavenger receptor Class B Type I loaded ultrasound contrast agent be a new method for treating atherosclerosis?
    (Jiang Y, et al. Med Hypotheses. 2009 Mar 5. [Epub ahead of print])
    View Abstract
  • Computed tomography evaluation of intracranial atherosclerosis in Chinese patients with transient ischemic attack or minor ischemic stroke--its distribution and association with vascular risk factors.
    (Mak HK, et al. J Stroke Cerebrovasc Dis. 2009 Mar-Apr;18(2):158-63.)
    View Abstract

IMMUNOLOGY

  • Antiphospholipid antibodies from a patient with primary antiphospholipid syndrome enhance experimental atherosclerosis.
    (Adler A, et al. Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):215-8. Epub 2009 Jan 13.)
    View Abstract
  • No association between Parachlamydia infection and atherosclerosis.
    (Auderset F, et al. FEMS Immunol Med Microbiol. 2009 Mar;55(2):237-9. Epub 2008 Nov 21.)
    View Abstract
  • Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients.
    (Cacciapaglia F, et al. Lupus. 2009 Mar;18(3):249-56.)
    View Abstract
  • The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis.
    (van Leeuwen M, et al. Autoimmun Rev. 2009 Mar 11. [Epub ahead of print])
    View Abstract
  • Translational mini-review series on immunology of vascular disease: Accelerated atherosclerosis in vasculitis.
    (Cohen Tervaert JW. Clin Exp Immunol. 2009 Mar 20. [Epub ahead of print])
    View Abstract
  • Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis.
    (Reiss AB, et al. Exp Biol Med (Maywood). 2009 Mar;234(3):354-60. Epub 2009 Jan 14.)
    View Abstract

INFLAMMATION

  • Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis.
    (MacDonald ML, et al. Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):341-7. Epub 2008 Dec 18.)
    View Abstract

INNOVATIVE TECHNIQUES / MODELING

  • Adipose tissue transplantation may be a potential treatment for diabetes, atherosclerosis and nonalcoholic steatohepatitis.
    (Sanal MG. Med Hypotheses. 2009 Mar;72(3):247-9. Epub 2008 Nov 28.)
    View Abstract

METABOLIC SYNDROME

  • Body mass index, metabolic syndrome and carotid atherosclerosis.
    (Irace C, et al. Coron Artery Dis. 2009 Mar;20(2):94-9.)
    View Abstract
  • Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
    (Malik S, et al. Expert Rev Cardiovasc Ther. 2009 Mar;7(3):273-80.)
    View Abstract

NUTRITION, DIET AND METABOLISM

  • Supplement use contributes to meeting recommended dietary intakes for calcium, magnesium, and vitamin C in four ethnicities of middle-aged and older Americans: the Multi-Ethnic Study of Atherosclerosis.
    (Burnett-Hartman AN, et al. J Am Diet Assoc. 2009 Mar;109(3):422-9.)
    View Abstract
  • Availability of healthy foods and dietary patterns: the Multi-Ethnic Study of Atherosclerosis.
    (Franco M, et al. Am J Clin Nutr. 2009 Mar;89(3):897-904. Epub 2009 Jan 14.)
    View Abstract
  • High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial.
    (Hodis HN, et al. Stroke. 2009 Mar;40(3):730-6. Epub 2008 Dec 31.)
    View Abstract
  • Early prevention by L-Arginine attenuates coronary atherosclerosis in a model of hypercholesterolemic animals; no positive results for treatment.
    (Javanmard SH, et al. Nutr Metab (Lond). 2009 Mar 24;6:13.)
    View Abstract
  • Association of serum sodium concentration with coronary atherosclerosis in China: follow-up study.
    (Jia EZ, et al. Acta Pharmacol Sin. 2009 Apr;30(4):494-500. Epub 2009 Mar 23.)
    View Abstract
  • Role of Folic Acid in Atherosclerosis After Kidney Transplant: A Double-blind, Randomized, Placebo-controlled Clinical Trial.
    (Nafar M, et al. Exp Clin Transplant. 2009 Mar;7(1):33-9.)
    View Abstract
  • Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins.
    (Sirtori CR, et al. Atherosclerosis. 2009 Mar;203(1):8-17. Epub 2008 Jul 1.)
    View Abstract
  • Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits.
    (Prasad K. J Cardiovasc Pharmacol Ther. 2009 Mar;14(1):38-48.)
    View Abstract
  • Resveratrol toxicity: Effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets.
    (Rocha KK, et al. Food Chem Toxicol. 2009 Mar 17. [Epub ahead of print])
    View Abstract
  • Carbohydrate intake modifies associations between ANGPTL4[E40K] genotype and HDL-cholesterol concentrations in White men from the Atherosclerosis Risk in Communities (ARIC) study.
    (Nettleton JA, et al. Atherosclerosis. 2009 Mar;203(1):214-20. Epub 2008 Jul 2.)
    View Abstract

OBESITY

  • Social stress, visceral obesity, and coronary artery atherosclerosis in female primates.
    (Shively CA, et al. Obesity (Silver Spring). 2009 Mar 26. [Epub ahead of print])
    View Abstract

OXIDATIVE STRESS

  • Vitamin C intake attenuates the degree of experimental atherosclerosis induced by periodontitis in the rat by decreasing oxidative stress.
    (Ekuni D, et al. Arch Oral Biol. 2009 May;54(5):495-502. Epub 2009 Mar 17.)
    View Abstract

PEDIATRICS

  • Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome.
    (Kniazewska MH, et al. Pediatr Nephrol. 2009 Mar;24(3):549-54. Epub 2008 Oct 30.)
    View Abstract

PLAQUE BIOLOGY

  • Effect of atherosclerosis on thermo-mechanical properties of arterial wall and its repercussion on plaque instability.
    (Guinea GV, et al. Int J Cardiol. 2009 Mar 6;132(3):444-6. Epub 2008 Mar 4.)
    View Abstract
  • Vulnerable plaque in a Swine model of carotid atherosclerosis.
    (Shi ZS, et al. AJNR Am J Neuroradiol. 2009 Mar;30(3):469-72. Epub 2009 Jan 15.)
    View Abstract

RENAL FUNCTION / RENAL DISEASE

  • The differential association of kidney dysfunction with small and large arterial elasticity: the multiethnic study of atherosclerosis.
    (Peralta CA, et al. Am J Epidemiol. 2009 Mar 15;169(6):740-8. Epub 2009 Jan 8.)
    View Abstract
  • Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?
    (Pertosa G, et al. Am J Kidney Dis. 2009 Mar;53(3):467-74. Epub 2009 Jan 23.)
    View Abstract
  • The association of cell cycle checkpoint 2 variants and kidney function: Findings of the Family Blood Pressure Program and the Atherosclerosis Risk in Communities Study.
    (Franceschini N, et al. Am J Hypertens. 2009 Mar 5. [Epub ahead of print])
    View Abstract

RISK FACTORS

  • Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.
    (Chen H, et al. Am J Epidemiol. 2009 May 1;169(9):1064-9. Epub 2009 Mar 18.)
    View Abstract
  • Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients.
    (Chiche F, et al. Atherosclerosis. 2009 Mar;203(1):269-76. Epub 2008 Jun 21.)
    View Abstract
  • Migration at early age from a high to a lower coronary heart disease risk country lowers the risk of subclinical atherosclerosis in middle-aged men.
    (Jartti L, et al. J Intern Med. 2009 Mar;265(3):345-58.)
    View Abstract
  • Fine particulate matter air pollution, proximity to traffic, and aortic atherosclerosis.
    (Allen RW, et al. Epidemiology. 2009 Mar;20(2):254-64.)
    View Abstract
  • Smoking cessation and subclinical atherosclerosis--results from the Heinz Nixdorf Recall Study.
    (Jöckel KH, et al. Atherosclerosis. 2009 Mar;203(1):221-7. Epub 2008 Jul 7.)
    View Abstract
  • Atherosclerosis and disc degeneration/low-back pain - A systematic review.
    (Kauppila LI. Eur J Vasc Endovasc Surg. 2009 Mar 25. [Epub ahead of print])
    View Abstract
  • Obstructive sleep apnea and atherosclerosis.
    (Lévy P, et al. Prog Cardiovasc Dis. 2009 Mar-Apr;51(5):400-10. Review.)
    View Abstract
  • Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits.
    (Mohammadi A, et al. Exp Toxicol Pathol. 2009 Mar;61(2):145-9. Epub 2008 Oct 5.)
    View Abstract
  • Hypoxia during pregnancy in rats leads to early morphologic changes of atherosclerosis in adult offspring.
    (Wang Z, et al. Am J Physiol Heart Circ Physiol. 2009 Mar 20. [Epub ahead of print])
    View Abstract
STROKE
  • The influence of anemia on clinical presentation and outcome of patients with first-ever atherosclerosis-related ischemic stroke.
    (Huang WY, et al. J Clin Neurosci. 2009 May;16(5):645-9. Epub 2009 Mar 12.)
    View Abstract
  • Autopsy prevalence of proximal extracranial atherosclerosis in patients with fatal stroke.
    (Mazighi M, et al. Stroke. 2009 Mar;40(3):713-8. Epub 2008 Dec 31.)
    View Abstract
  • Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement, but not with carotid atherosclerosis.
    (Sykora M, et al. Stroke. 2009 Mar;40(3):737-42. Epub 2008 Dec 31.)
    View Abstract
  • The association between inflammatory markers and carotid atherosclerosis is sex dependent: the Tromsø Study.
    (Halvorsen DS, et al. Cerebrovasc Dis. 2009;27(4):392-7. Epub 2009 Mar 10.)
    View Abstract
  • Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment. The Framingham Study.
    (Romero JR, et al. Stroke. 2009 Mar 5. [Epub ahead of print])
    View Abstract
  • Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).
    (Bui AL, et al. Am J Kidney Dis. 2009 Mar;53(3):389-98. Epub 2008 Sep 27.)
    View Abstract
  • Radiation-associated carotid artery atherosclerosis: case report and review of contemporaneous literature.
    (Friedlander AH, et al. Spec Care Dentist. 2009 Mar-Apr;29(2):75-9.)
    View Abstract
  • Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis.
    (Lester SJ, et al. Mayo Clin Proc. 2009 Mar;84(3):229-33.)
    View Abstract
  • ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.
    (Meuwese MC, et al. JAMA. 2009 Mar 18;301(11):1131-9.)
    View Abstract
  • Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study.
    (Vikan T, et al. Eur J Epidemiol. 2009 Mar 5. [Epub ahead of print])
    View Abstract
  • The relationships among serum glucose, albumin concentrations and carotid atherosclerosis in men with spinal cord injury.
    (Wang YH, et al. Atherosclerosis. 2009 Mar 14. [Epub ahead of print])
    View Abstract
VASCULAR BIOLOGY
  • Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
    (Antoniades C, et al. Eur Heart J. 2009 Mar 18. [Epub ahead of print])
    View Abstract
  • Cyclooxygenase inhibitors repress vascular hyaluronan-synthesis in murine atherosclerosis and neointimal thickening.
    (Marzoll A, et al. J Cell Mol Med. 2009 Mar 17. [Epub ahead of print])
    View Abstract
  • The possible role of red blood cell microvesicles in atherosclerosis.
    (Blum A. Eur J Intern Med. 2009 Mar;20(2):101-5. Epub 2008 Jul 24.)
    View Abstract
  • HSP 70 and atherosclerosis--protector or activator?
    (Bielecka-Dabrowa A, et al. Expert Opin Ther Targets. 2009 Mar;13(3):307-17.)
    View Abstract
  • Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density receptor knockout mice.
    (Bischoff ED, et al. J Lipid Res. 2009 Mar 30. [Epub ahead of print])
    View Abstract
  • Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice.
    (de Vries-van der Weij J, et al. Atherosclerosis. 2009 Mar 19. [Epub ahead of print])
    View Abstract
  • Race/ethnicity and telomere length in the Multi-Ethnic Study of Atherosclerosis.
    (Diez Roux AV, et al. Aging Cell. 2009 Mar 16. [Epub ahead of print])
    View Abstract
  • Vasa vasorum hypoxia: Initiation of atherosclerosis.
    (Järvilehto M, et al. Med Hypotheses. 2009 Mar 3. [Epub ahead of print])
    View Abstract
  • Apolipoprotein CIII links dyslipidemia with atherosclerosis.
    (Kawakami A, et al. J Atheroscler Thromb. 2009 Mar;16(1):6-11. Epub 2009 Mar 5.)
    View Abstract
  • An emerging paradigm in atherosclerosis: focus on subclinical disease.
    (Miller M. Postgrad Med. 2009 Mar;121(2):49-59. Review.)
    View Abstract
  • Nitric Oxide, NAD(P)H oxidase and atherosclerosis.
    (Muller G, et al. Antioxid Redox Signal. 2009 Mar 3. [Epub ahead of print])
    View Abstract
  • LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
    (Quinet EM, et al. J Lipid Res. 2009 Mar 24. [Epub ahead of print])
    View Abstract
  • VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.
    (VanderLaan PA, et al. J Lipid Res. 2009 Mar;50(3):376-85. Epub 2008 Oct 28.)
    View Abstract
  • Maternal stress and development of atherosclerosis in the adult apolipoprotein E-deficient mouse offspring.
    (Andersson IJ, et al. Am J Physiol Regul Integr Comp Physiol. 2009 Mar;296(3):R663-71. Epub 2009 Jan 7.)
    View Abstract

VASCULAR CALCIFICATION

  • Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis.
    (Giles JT, et al. Arthritis Res Ther. 2009 Mar 10;11(2):R36. [Epub ahead of print])
    View Abstract
  • Spatial QRS-T angle in peritoneal dialysis patients: association with carotid artery atherosclerosis, coronary artery calcification and troponin T.
    (Jaroszynski A, et al. Nephrol Dial Transplant. 2009 Mar;24(3):1003-8. Epub 2008 Oct 31.)
    View Abstract
  • Effects of calcimimetic on vascular calcification and atherosclerosis in uremic mice.
    (Joki N, et al. Bone. 2009 Mar 19. [Epub ahead of print])
    View Abstract
  • Reproducibility of coronary artery calcified plaque with cardiac 64-MDCT: the Multi-Ethnic Study of Atherosclerosis.
    (Budoff MJ, et al. AJR Am J Roentgenol. 2009 Mar;192(3):613-7.)
    View Abstract

RECOMMENDED READING

  • Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia.
    Izem L, Morton RE.
    J Lipid Res. 2009 Apr;50(4):676-84. Epub 2008 Nov 13.
    View Abstract
  • Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.
    van Himbergen TM, Matthan NR, Resteghini NA, Otokozawa S, Ai M, Stein EA, Jones PH, Schaefer EJ.
    J Lipid Res. 2009 Apr;50(4):730-9. Epub 2008 Nov 30.
    View Abstract
  • Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial.
    Goldenberg I, Boyko V, Tennenbaum A, Tanne D, Behar S, Guetta V.
    Arch Intern Med. 2009 Mar 9;169(5):508-14.
    View Abstract
  • Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis.
    Brunham LR, Singaraja RR, Duong M, Timmins JM, Fievet C, Bissada N, Kang MH, Samra A, Fruchart JC, McManus B, Staels B, Parks JS, Hayden MR.
    Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):548-54. Epub 2009 Feb 5.
    View Abstract
  • Serine palmitoyltransferase subunit 1 is present in the endoplasmic reticulum, nucleus and focal adhesions, and functions in cell morphology.
    Wei J, Yerokun T, Leipelt M, Haynes CA, Radhakrishna H, Momin A, Kelly S, Park H, Wang E, Carton JM, Uhlinger DJ, Merrill AH Jr.
    Biochim Biophys Acta. 2009 Apr 8. [Epub ahead of print]
    View Abstract
  • Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1.
    Stefulj J, Panzenboeck U, Becker T, Hirschmugl B, Schweinzer C, Lang I, Marsche G, Sadjak A, Lang U, Desoye G, Wadsack C.
    Circ Res. 2009 Mar 13;104(5):600-8. Epub 2009 Jan 22.
    View Abstract
  • Hypoalphalipoproteinemia in populations of Native American ancestry: an opportunity to assess the interaction of genes and the environment.
    Aguilar-Salinas CA, Canizales-Quinteros S, Rojas-Martínez R, Mehta R, Villarreal-Molina MT, Arellano-Campos O, Riba L, Gómez-Pérez FJ, Tusié-Luna MT.
    Curr Opin Lipidol. 2009 Apr;20(2):92-7.
    View Abstract
  • ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.
    Meuwese MC, de Groot E, Duivenvoorden R, Trip MD, Ose L, Maritz FJ, Basart DC, Kastelein JJ, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA; CAPTIVATE Investigators.
    JAMA. 2009 Mar 18;301(11):1131-9.
    View Abstract
  • Severe HDL deficiency due to novel defects in the ABCA1 transporter.
    Pisciotta L, Bocchi L, Candini C, Sallo R, Zanotti I, Fasano T, Chakrapani A, Bates T, Bonardi R, Cantafora A, Ball S, Watts G, Bernini F, Calandra S, Bertolini S.
    J Intern Med. 2009 Mar;265(3):359-72. Epub 2008 Oct 25.
    View Abstract
  • New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism.
    Calpe-Berdiel L, Escolà-Gil JC, Blanco-Vaca F.
    Atherosclerosis. 2009 Mar;203(1):18-31. Epub 2008 Jul 6.
    View Abstract